KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Free Cash Flow (2016 - 2025)

Quest Diagnostics' Free Cash Flow history spans 17 years, with the latest figure at $465.0 million for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 36.36% year-over-year to $465.0 million; the TTM value through Dec 2025 reached $1.9 billion, up 107.48%, while the annual FY2025 figure was $1.9 billion, 107.48% up from the prior year.
  • Free Cash Flow for Q4 2025 was $465.0 million at Quest Diagnostics, down from $563.0 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $645.0 million in Q1 2021 and bottomed at -$33.0 million in Q1 2023.
  • The 5-year median for Free Cash Flow is $358.5 million (2021), against an average of $360.3 million.
  • The largest annual shift saw Free Cash Flow plummeted 106.88% in 2023 before it surged 528.0% in 2025.
  • A 5-year view of Free Cash Flow shows it stood at $337.0 million in 2021, then dropped by 0.89% to $334.0 million in 2022, then surged by 36.23% to $455.0 million in 2023, then dropped by 25.05% to $341.0 million in 2024, then surged by 36.36% to $465.0 million in 2025.
  • Per Business Quant, the three most recent readings for DGX's Free Cash Flow are $465.0 million (Q4 2025), $563.0 million (Q3 2025), and $544.0 million (Q2 2025).